Objective: To evaluate the results of two operations, aortic valve-sparing
and aortic root replacement, in patients with aortic root aneurysm and the
Marfan syndrome. Methods: A retrospective review of 78 consecutive patients
with aortic root aneurysm and the Marfan syndrome according to the Gent cr
iteria indicated that 42 patients with normal aortic cusps had an aortic va
lve-sparing operation, and 36 patients had aortic root replacement (mechani
cal valve in 25 patients and biological valve in ii). The mean age was simi
lar in both groups, but patients who had aortic root replacement had larger
aneurysms, higher grade aortic insufficiency, worse left ventricular funct
ion and more cardiac co-morbidity than patients who had aortic valve-sparin
g operations. The mean follow-up was 41 +/- 35 months for patients who had
aortic valve-sparing, and 65 +/- 50 months for those who had aortic root re
placement. Results: Kaplan-Meyer estimates of survival at 5 years was 100%
for patients who had aortic valve-sparing, and 88 +/- 6% for those who had
aortic root replacement (P = 0.04). Five patients who had aortic root repla
cement required seven aortic root re-replacements: three for endocarditis a
nd four for valve failure (biological valves). There have been no reoperati
ons in patients who had aortic valve-sparing operations and annual Doppler
echocardiography revealed mild or no aortic insufficiency in 39 patients an
d moderate aortic insufficiency in three. Conclusions: These data suggest t
hat aortic valve-sparing operations are safe in patients with the Marfan sy
ndrome and may provide better clinical outcomes than aortic root replacemen
t. Since the size of the aneurysm often determines the feasibility of a val
ve-sparing procedure, we now recommend surgery when the diameter of the aor
tic root reaches 50 mm in patients with the Marfan syndrome who have echoca
rdiographically normal aortic valve cusps. (C) 2000 Elsevier Science B.V. A
ll rights reserved.